Mass spectral characterization

Separation Science and Technology

Volumn 5, Issue C, 2004, Pages 249-299

  Burinskyand, David J ^a   Wang, Feng ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954755648     PISSN: 18771718     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0149-6395(03)80013-3     Document Type: Book

References (185)

1. Gorog, S. Identification and Determination of Impurities in Drugs. Elsevier, Amsterdam, 2000.
2. Norwood, D. L., Prime, D., Downey, B. P., Creasey, J., Sethi, S. K. and Haywood, P. Analysis of polycyclic aromatic hydrocarbons in metered dose inhaler drug formulations by isotope dilution gas chromatography/mass spectrometry. J. Pharm. Biomed. Anal. 13: 293-304, 1995.
3. Paskiet, D. M. Strategy for determining extractables from rubber packaging materials in drug products. PDA J. Pharm. Sci. Technol. 51:248-251. 1997.
4. Tiller, P. R., El Fallah, Z., Wilson, V., Juysman, J. and Patel, D. Qualitative assessment of leachables using data-dependent liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 11:1570-1574, 1997.
5. Wu, S.-L., Wang, Y. J., Hu, J. and Leung, D. The detection of the organic extractables in a biotech product by liquid chromatography online with electrospray mass spectrometry. PDA ]. Pharm. Sci. Technol. 51:229-237, 1997.
6. ICH Guideline: Impurities in New Drug Products, Federal Register, 62, No. 96, p. 27454ff. (May 19, 1997).
7. Kapadia, A. J. and Autian, J. The stability of secobarbital sodium solutions. II. Separation and identification of degradation products of secobarbital sodium. J. Am. Pharm. Assoc, Set. Ed. 49:380-382, 1960.
8. Gruber, M. P., Klein, R. W. and Foxx, M. Infrared and thin-layer chromatography determination of benzoyl peroxide degradation products in pharmaceuticals. J. Pharm. Sci. 58:566-569, 1969.
9. Gyanchandani, N. D., McGilveray, I. J. and Hughes, D. W. Improved thin-layer chromatographic identification of tetracyclines and their degradation products: application to an epimerization study. J. Pharm. Sci. 59:224-228, 1970.
10. Diding, E., Sandstrom, H., OsteHus, J., Karlen, B. and Bogentoft, C. Studies on the application of integrated gas chromatography-mass spectrometry in drug purity control. Impurities in clofibrate, norethindrone, methandienone, haloperidol and meladrazine. Acta Pharm. Suec. 13:55-64, 1976.
11. Johansson, E. and Ryhage, R. Gas chromatographic-mass spectrometric identification and determination of residual by-products in clofibrate preparations. J. Pharm. Pharmacol. 28: 927-929, 1976.
12. Ogorka, J., Schwinger, G., Bruat, G. and Seidel, V. Online coupled reversed-phase highperformance liquid chromatography-gas chromatography-mass spectrometry. A powerful tool for the identification of unknown impurities in pharmaceutical products. J. Chromatogr. 626:87-96, 1992.
13. Wessels, P., Ogorka, J., Schwinger, G. and Ulmer, M. Elucidation of the structure of drug degradation products by online coupled reversed phase HPLC-GC-MS and online derivatization. J. High Resolut. Chromatogr. 16:708-712, 1993.
14. Karger, B. L., Kirby, D. P., Vouros, P., Foltz, R. L. and Hidy, B. On-line reversed phase liquid chromatography-mass spectrometry. Anal. Chem. 51:2324-2328, 1979.
15. Arpino, P. J., Guiochon, G., Krien, P. and Devant, G. Optimization of the instrumental parameters of a combined liquid chromatograph-mass spectrometer, coupled by an interface for direct liquid introduction I: Performance of the vacuum equipment. J. Chromatogr. 185: 529-547, 1979.
16. Ashcroft, A. E., Chapman, J. R. and Cottrell, J. S. Continuous-flow fast atom bombardment mass spectrometry. J. Chromatogr. 394:15-20, 1987.
17. Voyksner, R. D. and Haney, C. A. Optimization and application of thermospray highperformance liquid chromatography/mass spectrometry. Anal. Chem. 57:991-996, 1985.
18. Whitehouse, C. M., Dreyer, R. N., Yamashita, M. and Fenn, J. B. Electrospray interface for liquid chromatographs and mass spectrometers. Anal. Chem. 57:675-679, 1985.
19. Henion, J. D., Thomson, B. A. and Dawson, P. H. Determination of sulfa drugs in biological fluids by liquid chromatography/mass spectrometry/mass spectrometry. Anal. Chem. 54: 451-456, 1982.
20. Ahuja, S. Impurity analysis of pharmaceutical compounds. Chem. Anal. 85:195-216, 1986.
21. Berridge, J. C. Impurities in drug substances and drug products: new approaches to quantification and qualification. J. Pharm. Biomed. Anal. 14:7-12, 1995.
22. Goosens, E. C, Stegman, K. H., de Jong, D., de Jong, G. J. and Brinkman, U. A. T. Investigation of online reversed-phase liquid chromatography-gas chromatography-mass spectrometry as a tool for the identification of impurities in drug substances. Analyst. 121:61-66, 1996.
23. Gorog, S. Identification, structure elucidation and determination of related organic impurities 2.1. Strategies in impurity profiling. Prog. Pharm. Biomed. Anal. 4:67-83, 2000.
24. Gorog, S. Selected examples (impurity profiling of some groups of drugs) 9.1. Peptides. Prog. Pharm. Biomed. Anal. 4:639-659, 2000.
25. Ermer, J. and Vogel, M. Applications of hyphenated LC-MS techniques in pharmaceutical analysis. Biomed. Chromatogr. 14:373-383, 2000.
26. Gorog, S. The role of the diode-array UV spectra in the identification of impurities. Prog. Pharm. Biomed. Anal. 4:252-265, 2000.
27. Mak, M., Czira, G. and Brhk, J. Mass spectrometry in impurity profiling. Prog. Pharm. Biomed. Anal. 4:97-108, 2000.
28. Tollsten, L. HPLC/MS for drug impurity identification. Prog. Pharm, Biomed. Anal. 4: 266-298, 2000.
29. Wu, Y. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations. Biomed. Chromatogr. 14:384-396, 2001.
30. Alsante, K. M., Hatajik, T. D., Lohr, L. L. and Sharp, T. R. Isolation and identification of process related impurities and degradation products from pharmaceutical drug candidates: part I Am. Pharm. Rev. 4:70-78, 2001.
31. Lohr, L. L., Sharp, T. R., Alsante, K. M. and Hatajik, T. D. Isolation and identification of process related impurities and degradation products from pharmaceutical drug candidates: part II Am. Pharm. Rev. 4:104-113, 2001.
32. Reynolds, D. W., Facchine, K. L., Mullaney, J. F., Alsante, K. M., Hatajik, T. D. and Motto, M. G. Conducting forced degradation studies. Pharm. Tech. 26:48-56, 2002.
33. Nicolas, E. C. and Scholz, T. H., Active drug substance impurity profiling. Part I. LC/UV diode array spectral matching. J. Pharm. Biomed. Anal. 16:813-824, 1998.
34. Gorog, S. and Herenyi, B. Analysis of steroids. XXXVIII. The use of high-performance liquid chromatography with diode-array UV detection for estimating impurity profiles of steroid drugs. J. Chromatogr. 400:177-186, 1987.
35. Czech, M. A., Meltzer, M. and Mouskountakis, J. Determination of Ro 14-4767 (Loceryl) by LC using automated column switching with ultraviolet and electrochemical detection. J. Pharm. Biomed. Anal. 9:1019-1029, 1991.
36. Gorog, S., Bihari, M., Csizer, E., Dravetz, F., Gazdag, M. and Herenyi, B. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrixes. J. Fhann. Biomed. Anal. 14:85-92, 1995.
37. Mack, G. D. and Ashworth, R. B. A high performance liquid chromatographic system for the analysis of tetracycline drug standards, analogs, degradation products and other impurities. J. Chromatogr. Sci. 16:93-101, 1978.
38. Graham, K. C., LeBelle, M. J. and Wilson, W. L. High performance liquid chromatographic analysis of rifampin and related impurities in pharmaceutical formulations. J. Liq. Chromatogr. 2:365-371, 1979.
39. Mount, D. L., Miles, J. W. and Churchill, F. C. Liquid chromatographic and spectroscopic characterization of pentamidine isethionate and impurities in bulk drug and injectables. J. Assoc. Off. Anal. Chem. 69:624-629, 1986.
40. Cyr, T. D., Matsui, F., Sears, R. W., Curran, N. M. and Lovering, E. G. Liquid chromatographic methods for assay of carbamazepine, 10,11-dihydrocarbamazepine, and related compounds in carbamazepine drug substance and tablets. J. Assoc. Off. Anal. Chem. 70:836-840, 1987.
41. Wannerberg, O. and Persson, B. Liquid chromatographic method for the determination of bambuterol hydrochloride and related compounds. J. Chromatogr. 435:199-203, 1988.
42. Betto, P., Ciranni-Signoretti, E. and Di Fava, R. Determination of cimetidine and related impurities in pharmaceutical formulations by high-performance liquid chromatography. J. Chromatogr. 586:149-152, 1991.
43. Gorski, R. J., Morgan, D. K., Sarocka, C. and Plasz, A. C. Estimation and identification of non-polar compounds in clarithromycin bulk drug by high-performance liquid chromatography. J. Chromatogr. 540:422-429, 1991.
44. Kersten, B. S., Catalano, T. and Rozenman, Y. Ion-pairing high-performance liquid chromatographic method for the determination of 5-aminosalicylic acid and related impurities in bulk chemical. J. Chromatogr. 588:187-193, 1991.
45. Beaulieu, N., Graham, S. J., Sears, R. W. and Lovering, E. G. Liquid chromatographic determination of alprazolam and related impurities in drug substance. J. AOAC Int. 75: 801-804, 1992.
46. Elrod, L. Jr., Golich, T. G., Shaffer, D. I. and Shelat, B. P. Determination of 6,7-difluoro-l-(2,4-difluorophenyl)-l,4-dihydro-4-oxo-3-quinilinecarboxylic acid and related compounds by high performance liquid chromatography. J. Liq. Chromatogr. 15:451-466, 1992.
47. Baran, H. and Schwedt, G. Identification of degradation products from epinephrine (adrenaline) in infusion solutions by HPLC and multidetection. Pharmazie. 48:273-275, 1993.
48. Bauer, J. F., Krogh, S. K., Chang, Z. L. and Wong, C. F. Determination of minor impurities in terazosin hydrochloride by high-performance liquid chromatography. J. Chromatogr. 648:175-181, 1993.
49. Priestner, A. A. Use of radiolabeled drug substance to investigate mass balance during validation of a high-performance liquid chromatography method for impurities. Anal. Proc. 30:374-377, 1993.
50. Golich, T. G., Eldrod, L. Jr. and Morley, J. A. Determination of minor impurities and diastereomers of 6-[3-[(2-amino-l-oxopentyl)amino]-l-pyrrolidinyl]-5-fluoro-3-oxo-3Flpyrido 13,2,l-kl]phenoxazine-2-carboxylic acid hydrochloride by high performance liquid chromatography. J. Liq. Chromatogr. 17:2005-2016, 1994.
51. Golich, T. G., Thomsen, J. R., Green, D. L. and Jersild, J. Determination of minor impurities of (R)-l-acetoxymethyl-3-(7-[(l-N,N-dimethylcarbamoyl)-6-(4-fluorophenyl)-indol-3-oyl]-lH, 3H-pyrrolo[l,2-c]thiazol-3-yl)pyridinium chloride by high performance liquid chromatography. J. Liq. Chromatogr. 18:4107-4116, 1995.
52. Orsi, D. D., Gagliardi, L., Chimenti, F. and Tonelli, D. FiPLC determination of beclomethasone dipropionate and its degradation products in bulk drug and pharmaceutical formulations. Anal. Lett. 28:1655-1663, 1995.
53. Stemm, N. L., Skoug, J, W. and Robins, R. H. Gradient high-performance Uquid chromatographic assay for degradation products of adinazolam mesylate in a sustained-release tablet formulation. Pharin. Res. 12:738-745, 1995.
54. Bernal, J. L., del Nazal, M. J., Velasco, H. and Toribio, L. HPLC versus SFC for the determination of salbutamol sulfate and its impurities in pharmaceuticals. J. Liq. Chromatogr. Relat. Technol. 19:1579-1589, 1996.
55. Doub, W. H., Ruhl, D. D., Hart, B., Mehelic, P. R. and Revelle, L. K. Gradient liquid chromatographic method for determination of chlorhexidine and its degradation products in bulk material. J. AOAC Int. 79:636-639, 1996.
56. Olori, L., Pierini, N., Spagnoli, M. A. and Tranfo, G. Determination of impurities in buflomedil hydrochloride by HPLC. Boll. Chim. Farm. 135:342-350, 1996.
57. Faulkner, A. J., Wang, Q., DeMontigny, P. and Murphy, J. S. Stability studies and highperformance liquid chromatographic procedures for L-648,548 and its major degradates in an animal health formulation. J. Pharm. Biomed. Anal. 15:523-536, 1997.
58. Gamiz-Gracia, L. and De Castro, M. D. L. An HPLC method for the determination of vitamin Bl, caffeine, acetylsalicylic acid, and the impurities of salicylic acid in a pharmaceutical preparation. J. Liq. Chromatogr. Relat. Technol. 20:2123-2133, 1997.
59. Husain, S. and Nageswara R. R. High performance liquid chromatographic monitoring of process impurities in bulk drugs and formulations. Process Control Qual. 10:41-57, 1997.
60. Panderi, L, Archontaki, H., Gikas, E. and Parissi-Poulou, M. Acidic hydrolysis of bromazepam studied by high performance liquid chromatography. Isolation and identification of its degradation products. J. Pharm. Biomed. Anal. 17:327-335, 1998.
61. Al-Kurdi, Z., Al-Jallad, T., Badwan, A. and Jaber, A. M. Y. High performance liquid chromatography method for determination of methyl 5-benzoyl-2-benzimidazolecarbamate (mebendazole) and its main degradation product in pharmaceutical dosage forms. Talanta 50:1089-1097, 1999.
62. Xu, X. and Stew^art, J. T. HPLC analysis of haloperidol and its related compound in the drug substance and a tablet dosage form using a non-porous silica octadecylsilane column. J. Liq. Chromatogr. Relat. Technol. 22:1857-1866, 1999.
63. Vaidya, V. V., Khanolkar, M. and Gadre, J. N. Generation of trace impurity profile for tolnaftate by reverse phase high performance liquid chromatography. Indian Drugs 37: 521-523, 2000.
64. Daraghmeh, N., Al-Omari, M., Badwan, A. A. and Jaber, A. M. Y. Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC. J. Pharm. Biomed. Anal. 25:483-492, 2001.
65. Gjerde, H., Snotun, A., Hem, H., Larsen, K. H. and Dohl, J. Determination of mangafodipir trisodium and related impurities in bulk substance and pharmaceutical formulation by ion-pair high-performance liquid chromatography. J. Pharm. Biomed. Anal. 25:109-114, 2001.
66. Gomes, A. R. and Nagaraju, V. High-performance liquid chromatographic separation and determination of the process related impurities of mebendazole, fenbendazole and albendazole in bulk drugs. J. Pharm. Biomed. Anal. 26:919-927, 2001.
67. Loregian, A., Gatti, R., Palu, G. and De Palo, E. F. Separation methods for acyclovir and related antiviral compounds. J. Chromatogr., B: Biomed. Sci. Appl. 764:289-311, 2001.
68. Montgomery, E. R., Edmanson, A. L., Cook, S. C. and Hovsepian, P. K. Development and validation of a reverse-phase HPLC method for analysis of efavirenz and its related substances in the drug substance and in a capsule formulation. J. Pharm. Biomed. Anal. 25:267-284, 2001.
69. Ogorka, J., Schwinger, G., Bruat, G. and Seidel, V. Online coupled reversed-phase highperformance liquid chromatography-gas chromatography-mass spectrometry. A powerful tool for the identification of unknown impurities in pharmaceutical products. J. Chromatogr. 626:87-96, 1992.
70. Wessels, P., Ogorka, J., Schwinger, G. and Ulmer, M. Elucidation of the structure of drug degradation products by online coupled reversed phase HPLC-GC-MS and online derivatization. J. High Resolut. Chromatogr. 16:708-712, 1993.
71. Dette, C, Waetzig, H. and Uhl, H. Characterization of the important pharmaceutical intermediate pyridine-2,4-dicar boxy lie acid using capillary electrophoresis (CE). Pharmazie 48:276-280, 1993.
72. Tjoernelund, J. and Hansen, S. H. Determination of impurities in tetracycline hydrochloride by nonaqueous capillary electrophoresis. J. Chromatogr., A 737:291-300, 1997.
73. Hamdan, M. Pharmaceutical applications of liquid chromatography, capillary electrophoresis coupled to mass spectrometry. Process Control Qual. 10:113-127, 1997.
74. Ellis, D. R., Palmer, M. E., Tetler, L. W. and Eckers, C. Separation of cimetidine and related materials by aqueous and non-aqueous capillary electrophoresis. J. Chromatogr., A 808: 269-275, 1998.
75. Yesilada, A., Tozkoparan, B., Gokhan, N., Oner, L. and Ertan, M. Development and validation of a capillary electrophoretic method for the determination of degradation product in naphazoline HCl bulk drug substance. J. Liq. Chromatogr. Relat. Technol. 21: 2575-2588, 1998.
76. Okafo, G., Tolson, D., Monte, S. and Marchbank, J. Analysis of process impurities in the basic drug SB-253149 using capillary electrophoresis and on-line mass spectrometric detection. Rapid Commun. Mass Spectrom. 14:2320-2327, 2000.
77. Shafaati, A. and Clark, B. J. Determination of azathioprine and its related substances by capillary zone electrophoresis and its application to pharmaceutical dosage forms assay. Drug Dev. Ind. Pharm. 26:267-273, 2000.
78. Altria, K. D. High-speed determination of drug related impurities by capillary electrophoresis employing commercial instrumentation. J. Chromatogr. 636:125-132, 1993.
79. Ahrer, W., Schoftner, R. and Buchberger, W. Identification of unknown degradation products in a new cholesterol-reducing drug by ion-chromatography coupled to mass spectrometry. J. Chromatogr., A 912:91-98, 2001.
80. Gruber, M. P., Klein, R. W. and Foxx, M. Infrared and thin-layer chromatography determination of benzoyl peroxide degradation products in pharmaceuticals. J. Pharm. Set. 5S:566-569, 1969.
81. Gyanchandani, N. D., McGilveray, I. J. and Hughes, D. W. Improved thin-layer chromatographic identification of tetracyclines and their degradation products: application to an epimerization study. J. Pharm. Sci. 59:224-228, 1970.
82. Ponder, G. W. and Stewart, J. T. High-performance thin-layer chromatographic determination of digoxin and related compounds, digoxigenin bisdigitoxoside and gitoxin, in digoxin drug substance and tablets. J. Chromatogr. 659:177-183, 1994.
83. Crecelius, A., Clench, M. R., Richards, D. S., Mather, J. and Parr, V. Analysis of UK-224,671 and related substances by thin-layer chromatography-matrix-assisted laser-desorption ionization-time of flight mass spectrometry. J. Planar Chromatogr. Mod. TLC. 13:76-81, 2000.
84. Aboul-Enein, H. Y. and Abu-Zaid, S. Two-dimensional TLC method for identification and quantitative analysis of salbutamol and related impurities in pharmaceutical tablet formulation. Anal. Lett. 34:2099-2110, 2001.
85. Gorog, S., Balogh, G. and Gazdag, M. Analysis of steroids. XLIII. Estimation of impurity profiles of drugs and related materials. Part VIII: combined application of high-performance liquid chromatography and NMR spectroscopy in the impurity profiling of drugs. J. Pharm. Biomed. Anal. 9:829-833 1991.
86. Roberts, J. K. and Smith, R. J. Use of liquid chromatography-nuclear magnetic resonance spectroscopy for the identification of impurities in drug substances. J. Chromatogr., A 677: 385-389, 1994.
87. 19F LC/NMR: application to the identification of impurities in compounds of pharmaceutical interest. Pharm. Sci. 1:103-105, 1995.
88. Ruckmick, S. C, Marsh, D. F. and Duong, S. T. Synthesis and identification of the primary degradation product in a commercial ophthalmic formulation using NMR, MS, and a stability-indicating HPLC method for antazoline and naphazoline. J. Pharm. Sci. 84: 502-507, 1995.
89. Mistry, N., Ismail, I. M., Smith, M. S., Nicholson, J. K. and Lindon, J. C. Characterization of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLCNMR spectroscopy and HPLC-MS. J. Pharm. Biomed. Anal. 16:697-705, 1997.
90. Ryan, T. W. Identification of four process-related impurities in the bulk drug butalbital using HPLC-UV photodiode array detection, particle beam MS, and NMR. Anal. Lett. 31:2447-2456, 1998.
91. Peng, S. X., Borah, B., Dobson, R. L. M., Liu, Y. D. and Pikul, S. Application of LC-NMR and LC-MS to the identification of degradation products of a protease inhibitor in dosage formulations. J. Pharm. Biomed. Anal. 20:75-89, 1999.
92. Lehr, G. J., Barry, T. L., Petzinger, G., Hanna, G. M. and Zito, S. W. Isolation and identification of process impurities in trimethoprim drug substance by high-performance liquid chromatography, atmospheric pressure chemical ionization liquid chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy. J. Pharm. Biojned. Anal. 19:373-389, 1999.
93. El-Anwar and Fawzy, M. Use of HPLC and NMR for the study of cefonicid sodium stability and identification of a degradation product involved in allergic reactions. J. Drug Res. 23:73-77, 2000.
94. Lindon, J. C., Nicholson, J. K. and Wilson, I. D. Direcdy coupled HPLC-NMR and HPLCNMR-MS in pharmaceutical research and development. J. Chromatogr., B: Biomed. Sci. Appl. 748:233-258, 2000.
95. Hess, S., Teubert, U., Ortwein, J. and Eger, K. Profiling indomethacin impurities using highperformance liquid chromatography and nuclear magnetic resonance. Eur. J. Pharm. Sci. 14:301-311, 2001.
96. Harrison, A.G. Chemical ionization mass spectrometry Adv. Mass Spectrom. llA:582-595, 1989.
97. Barber, M., Bordoli, R. S., Sedgwick, R. D. and Tyler, A. N. Fast atom bombardment of solids (F.A.B.): a new ion source for mass spectrometry. J. Chem. Soc, Chem. Commun. 325-327, 1981.
98. Kerns, E. H., Volk, K. J., Hill, S. E. and Lee M. S. Profiling new taxanes using LC/MS and LC/MS/MS substructural analysis techniques. J. Rapid Commun. Mass Spectrom. 9:1539-1545, 1995.
99. Volk, K. J., Klohr, S. E., Rourick, R. A., Kerns, E.H. and Lee, M. S. Profiling impurities and degradants of butorphanol tartrate using liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry substructural techniques. J. Pharm. Biomed. Anal. 14, 1663-1674, 1996.
100. Biemann, K. High resolution mass spectrometry. Advan. Anal. Chem. Instrum. 8:185-221, 1970.
101. Abramson, F. P. Analytical applications of high resolution mass spectrometry. J. Chem. Educ. 49: A283-A293, 1972.
102. Kondrat, R. High resolution mass spectrometry. J. Am. Soc. Mass Spectrom. 10, 661, 1999.
103. Andren, P. E., Emmett, M. R. and Caprioli, R. M. Micro-electrospray: zeptomole/attomole per microliter sensitivity for peptides J. Am. Soc. Mass Spectrom. 5:867-869, 1994.
104. McLuckey, S. A., Cameron, D. and Cooks, R. G. Proton affinities from dissociations of proton-bound dimers. J. Am. Chem. Soc. 103:1313-1317, 1981.
105. Kissinger, P. T. Electrochemical detection in bioanalysis. J. Pharm. Biomed. Anal. 14:871-880, 1996.
106. Anderson, J. K., Hollaway, W. L. and Mole, J. E. Ion-pair reverse-phase HPLC of tryptic peptides from plasma amyloid P-component using a volatile buffer system. J. High Resolut. Chromatogr. Chromatogr. Commun. 4:417-418, 1981.
107. Patthy, M. and Gyenge, R. Perfluorinated acids as ion-pairing agents in the determination of monoamine transmitters and some prominent metabolites in rat brain by highperformance liquid chromatography with amperometric detection. J. Chromatogr. 449: 191-205, 1988.
108. Ayrton, J., Dear, G. J., Leavens, W. J., Mallett, D. N. and Plumb, R. S. Use of generic fast gradient liquid chromatography-tandem mass spectroscopy in quantitative bioanalysis. J. Chromatogr., B: Biomed. Sci. Appl. 709:243-254, 1998.
109. Leroy, F., Presle, B., Verillon, F. and Verette, E. Fast generic-gradient reversed-phase highperformance liquid chromatography using short narrow-bore columns packed with small nonporous silica particles for the analysis of combinatorial libraries. J. Chromatogr. Sci. 39:487-490, 2001.
110. Olah, T. V., McLoughlin, D. A. and Gilbert, J. D. The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure. Rapid Commun. Mass Spectrom. 11:17-23, 1997.
111. Smith, R. D., Barinaga, C. J. and Udseth, H. R. Improved electrospray ionization interface for capillary zone electrophoresis-mass spectrometry Anal. Chem. 60, 1948-1952, 1988.
112. Moseley, M. A., Deterding, L. J., Tomer, K. B. and Jorgenson, J. W. Coupling of capillary zone electrophoresis and capillary Hquid chromatography with coaxial continuous-flow fast atom bombardment tandem sector mass spectrometry. J. Chromatogr. 480, 197-209, 1989.
113. Lee, E. D., Mueck, W., Henion, J. D. and Covey, T. R. On-line capillary zone electrophoresis-ion spray mass spectrometry for the determination of dynorphins. J. Chromatogr. 458:313-321, 1988.
114. Reinhoud, N. J., Niessen, W. M. A., Tjaden, U. R., Gramberg, L. G., Verheij, E. R. and van der Greef, J. Performance of a liquid-junction interface for capillary electrophoresis mass spectrometry using continuous-flow fast-atom bombardment Rapid Commun. Mass Spectrom. 3:348-351, 1989.
115. Gale, D. C. and Smith, R. D. Small volume and low flow-rate electrospray ionization mass spectrometry of aqueous samples. Rapid Commun. Mass Spectrom. 7, 1017-1021, 1993.
116. Chowdhury, S. K. and Chait, B. T. Method for the electrospray ionization of highly conductive aqueous solutions. Anal. Chem. 63:1660-1664, 1991.
117. Wahl, J. H. and Smith, R. D., Comparison of buffer systems and interface designs for capillary electrophoresis-mass spectrometry. J. Cap. Elec. 1:62-71, 1994.
118. Pramanik, B. N., Bartner, P. L., Mirza, U. A., Liu, Y.-H. and Ganguly, A. K. Electrospray ionization mass spectrometry for the study of non-covalent complexes: an emerging technology. J. Mass Spectrom. 33:911-920, 1998.
119. De la Mora, J. F., Van Berkel, G. J., Enke, C. G., Cole, R. B., Martinez-Sanchez, M. and Fenn, J. B. Electrochemical processes in electrospray ionization mass spectrometry. J. Mass Spectrom. 35:939-952, 2000.
120. Thurman, E. M., Ferrer, L and Barcelo, D. Choosing between atmospheric pressure chemical ionization and electrospray ionization for the HPLC/MS analysis of pesticides. Anal. Chem. 73:5441-5449, 2001.
121. Mochida, Y., Yokoyama, Y. and Nakamura, S. Effect of ammonia addition to the mobile phase on atmospheric pressure chemical ionization mass spectrometry of methyl hydroperoxyoleates. J. Mass Spectrom. Soc. Japan 46:246-249, 1998.
122. Tong, W., Chowdhury, S. K., Chen, J. C, Zhong, R., Alton, K. B. and Patrick, J. E. Fragmentation of N-oxides (deoxygenation) in atmospheric pressure ionization: investigation of the activation process. Rapid Comm. Mass Spectrom. 15:2085-2090, 2001.
123. Burinsky, D. J., Williams, J. D., Thornquest, A. D. Jr. and Sides, S. L. Mass spectral fragmentation reactions of a therapeutic 4-azasteroid and related compounds. J. Am. Soc. Mass Spectrom. 12:385-398, 2001.
124. Robb, D. B., Covey, T. R. and Bruins, A. P. Atmospheric pressure photoionization: an ionization method for liquid chromatography-mass spectrometry. Anal. Chem. 72:3653-3659, 2000.
125. Hanold, K. A., Evans, M. D., Fischer, S. M., Cormia, P. H. and Syage, J. A. Photoionization interface for LC/MS. Abstr. Pap.-Am. Chem. Soc. 221st ANYL-108, 2001.
126. Rauha, J.-P., Vuorela, H. and Kostiainen, R. Effect of eluent on the ionization efficiency of flavinoids by ion spray, atmospheric pressure chemical ionization, and atmospheric pressure photoionization mass spectrometry. J. Mass Spectrom. 36:1269-1280, 2001.
127. Kemp, D. L., Beynon, J. H. and Cooks, R. G. Charge stripping and E/2 mass spectra. Org. Mass Spectrom. 11:857-866, 1976.
128. Loo, J. A., Loo, R. R. O., Udseth, H. R., Edmonds, C. G. and Smith, R. D. Solvent-induced conformational changes of polypeptides probed by electrospray-ionization mass spectrometry. Rapid Commun. Mass Spectrom. 5:101-105, 1991.
129. McLafferty, F. W. (1980). Interpretation of Mass Spectra, 3rd ed., Chapter 4. University Science Books, Mill Valley.
130. Deterding, L. J. and Gross, M. L. Tandem mass spectrometry for identifying fatty acid derivatives that undergo charge-remote fragmentations. Org. Mass Spectrom. 13:169-177, 1988.
131. Thomson, B. A., Douglas, D. J., Corr, J. J., Hager, J. W. and Jolliffe, C. L. Improved Collisionally Activated Dissociation Efficiency and Mass Resolution on a Triple Quadrupole Mass Spectrometer System. Anal. Chem. 67:1696-1704, 1995.
132. Williams, J. D., Cox, K. A., Cooks, R. C, Kaiser, R. E. Jr. and Schwartz, J. C. High massresolution using a quadrupole ion-trap mass spectrometer. Rapid Commun. Mass Spectrom. 5:327-329, 1991.
133. Jennings, K. R. Collision-induced decompositions of aromatic molecular ions. Int. J. Mass Spectrom. Ion Phys. 1:227-235, 1968.
134. Beynon, J. H., Morgan, R. P. and Brenton, A. G. New methods of identifying organic compounds. Philos. Trans. R. Soc. London, Ser. A 293:157-160, 1979.
135. Boyd, R. K., Porter, C. J. and Beynon, J. H. Linked-scan laws to detect fragmentations in the second field-free region of a double-focussing mass spectrometer. Int. J. Mass Spectrom. Ion Phys. 44:199-214, 1982.
136. Boyd, R. K., Porter, C. J. and Beynon, J. H. A new linked scan for reversed geometry mass spectrometers. Org. Mass Spectrom. 16:490-494, 1981.
137. Kemp, D. L., Cooks, R. G. and Beynon, J. H. Simulated mass-analyzed ion kinetic energy (MIKE) spectra from a conventional double focusing mass spectrometer. Int. J. Mass Spectrom. Ion Phys. 21:93-101, 1976.
138. Yost, R. A. and Enke, C. G. Selected ion fragmentation with a tandem quadrupole mass spectrometer. J. Am. Chem. Soc. 100:2274-2275, 1978.
139. Bean, M. P., Carr, S. A., Thorne, G. C, Reilly, M. H. and Gaskell, S. J. Tandem mass spectrometry of peptides using hybrid and four-sector instruments: a comparative study. Anal. Chem. 63:1473-1481, 1991.
140. Josephs, J. L. Detection and characterization of fumonisin mycotoxins by liquid chromatography/electrospray-ionization using ion trap and triple quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 10:1333-1344, 1996.
141. Stafford, G. C, Jr., Kelley, P. E., Syka, J. E. P., Reynolds, W. E. and Todd, J. F. J. Recent improvements in and analytical applications of advanced ion trap technology. Int. J. Mass Spectrom. Ion Processes. 60:85-98, 1984.
142. Baldeschwieler, J. D. Ion cyclotron resonance spectroscopy. Science. 159:263-273, 1968.
143. Comisarow, M. B. and Marshall, A. G. Fourier transform ion cyclotron resonance spectroscopy. Chem. Phys. Lett. 25:282-283, 1974.
144. Winger, B. E. and Kemp, C. A. J. Characterization of pharmaceutical compounds and related substances by using HPLC FTICR-MS and tandem mass spectrometry. Am. Pharm. Rev. 4:55-63, 2001.
145. Price, D. and Milnes, G. J. The renaissance of time-of-flight mass spectrometry. Int. J. Mass Spectrom. Ion Processes 99:1-39, 1990.
146. Gohlke, R. S. Time-of-flight mass spectrometry and gas-liquid partition chromatography. Anal. Chem. 31:535-541, 1959.
147. Mamyrin, B. A., Karataev, V. I., Shmikk, D. V. and Zagulin, V. A. Mass reflectron. New nonmagnetic time-of-flight high-resolution mass spectrometer. Zh. Eksp. Teor. Fiz. 64:82-89, 1973.
148. Beynon, J. H. Qualitative analysis of organic compounds by mass spectrometry. Nature 174:735-737, 1954.
149. Beckey, H. D. Field desorption mass spectrometry: a technique for the study of thermally unstable substances of low volatility. Int. J. Mass Spectrom. Ion Phys. 2:500-503, 1969.
150. Macfarlane, R. D. and Torgerson, D. F. Californium-252-plasma desorption time-of-flight mass spectrometry. Int. J. Mass Spectrom. Ion Phys. 21:81-92, 1976.
151. Karas, M., Bachmann, D., Bahr, U. and Hillenkamp, F. Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int. J. Mass Spectrom. Ion Processes 78:53-68, 1987.
152. McLafferty, F. W., Bente, P. F., III, Kornfeld, R., Tsai, S.-C. and Howe, I. Metastable ion characteristics XXII: Collisional activation spectra of organic ions. J. Amer. Chem. Soc. 95:2120-2129, 1973.
153. Mabud, M. A., Dekrey, M. J. and Cooks, R. G. Surface-induced dissociation of molecular ions. Int.]. Mass Spectrom. Ion Processes 67:285-294, 1985.
154. Harris, F. M., Mukhtar, E. S., Griffiths, I. W. and Beynon, J. H. Design of a high-resolution mass spectrometer for studying the photodissociation of organic ions in the gas phase. Proc. R. Soc. London, Ser. A 374:461-473, 1981.
155. Cody, R. B. and Preiser, B. S. Electron impact excitation of ions from organics: an alternative to collision induced dissociation. Anal. Chem. 51:547-551, 1979.
156. Aston, F. W. A positive-ray spectrograph. Phil. Mag. 38:707-715, 1919.
157. Hemberger, P. H., Laramee, J. A., Hubik, A. R. and Cooks, R. G. Angle-resolved mass spectrometry. Target effects upon energy deposition. J. Phys. Chem. 85:2335-2340, 1981.
158. Glish, G. L. and Todd, P. J. Collision region for mass spectrometry/mass spectrometry. Anal. Chem. 54:842-843, 1982.
159. Ast, T., Porter, C. J., Proctor, C. J. and Beynon, J. H. Charge stripping reactions in mass spectrometry: ionization energies of some mono- and disubstituted benzene ions. Glas. Hem. Drus. Beograd 46:135-151, 1981.
160. Schwartz, J. C, Syka, J. E. P. and Jardine, I. High resolution on a quadrupole ion trap mass spectrometer. J. Am. Soc. Mass Spectrom. 2:198-204, 1991.
161. Kaiser, R. £., Jr., Cooks, R. G., Moss, J. and Hemberger, P. H. Mass range extension in a quadrupole ion-trap mass spectrometer. Rapid Commun. Mass Spectrom. 3:50-53, 1989.
162. Rosenstock, H. M., Wallenstein, M. B, Wahrhaftig, A. L. and Eyring, H. Absolute rate theory for isolated systems and the mass spectra of polyatomic molecules. Proc. Natl. Acad. Sci. U.S. 38:667-678, 1952.
163. Lin, S. H., Lau, K. H., Richardson, W., Volk, L. and Eyring, H. Stochastic model of unimolecular reactions and the RRKM [Rice-Ramsperger-Kassel-Marcus] theory. Proc. Nat. Acad. Sci. U.S. 69:2778-2782, 1972.
164. Hart, K. J., Palmer, P. T., Diedrich, D. L. and Enke, C. G. Generation of substructure identification rules using feature-combinations from tandem mass spectra. J. Am. Soc. Mass Spectrom. 3:159-168, 1992.
165. Kerns, E. H., Volk, K. J., Hill, S. E. and Lee, M. S. Profiling new taxanes using LC/MS and LC/MS/MS substructural analysis techniques. Rapid Commun. Mass Spectrom. 9:1539-1545, 1995.
166. Volk, K. J., Klohr, S. E., Rourick, R. A., Kerns, E. H. and Lee M. S. Profiling impurities and degradants of butorphanol tartrate using liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry substructural techniques. J. Pharm. Biomed. Anal. 14:1663-1674, 1996.
167. Straub, K. M., Rudewicz, P. and Garvie, C. 'Metabolic mapping' of drugs: rapid screening techniques for xenobiotic metabolites with MS/MS techniques. Xenobiotica 17:413-422, 1987.
168. Tyczkowska, K. L., Voyksner, R. D. and Aronson, A. L. Solvent degradation of cloxacillin in vitro. Tentative identification of degradation products using thermospray liquid chromatography-mass spectrometry. J. Chromatogr. 594:195-201, 1992.
169. Pflumm, M. N., Gruber, S. C, Tsarbopoulos, A., Wylie, D., Pramanik, B., Bausch, J. N. and Patel, S. T. Isolation and characterization of an acetylated impurity in Escherichia coliderived recombinant human interleukin-10 (IL-10) drug substance. Pharm. Res. 14: 833-836, 1997.
170. DiPaolo, B., Pennetti, A., Nugent, L. and Venkat, K. Monitoring impurities in biopharmaceuticals produced by recombinant technology. Pharm. Sci. Technol. Today 2:70-82, 1999.
171. Oliva, A., Farina, J. and Llabres, M. Development of two high-performance liquid chromatographic methods for the analysis and characterization of insulin and its degradation products in pharmaceutical preparations. J. Chromatogr., B: Biomed. Sci. Appl. 749:25-34, 2000.
172. Eckers, C, Hutton, K. A., de Biasi, V., East, P. B., Haskins, N. J. and Jacewicz, V. W. Determination of clavam-2-carboxylate in clavulanate potassium and tablet material by liquid chromatography-tandem mass spectrometry. J. Chromatogr., A 686:213-218, 1994.
173. Weber, J. V., Sampino, K., Dunphy, R., Burinsky, D. J., Williams, T. and Motto, M. G. Characterization of cladribine and its related compounds by high-performance liquid chromatography/mass spectrometry. J. Pharm. Set. 83:523-531, 1994.
174. lavarone, L., Scandola, M., Pugnaghi, F. and Grossi, P. Qualitative analysis of potential metabolites and degradation products of a new antiinfective drug in rat urine, using HPLC with radiochemical detection and HPLC-mass spectrometry. J. Pharm. Biomed. Anal. 13:607-614, 1995.
175. Burinsky, D. J., Armstrong, B. L., Oyler, A. R. and Dunphy, R. Characterization of tepoxalin and its related compounds by high-performance liquid chromatography/mass spectrometry. J. Pharm. Sci. 85:159-164, 1996.
176. Nicolas, E. C. and Scholz, T. H. Active drug substance impurity profiling. Part II. LC/MS/ MS fingerprinting. J. Pharm. Biomed. Anal. 16:825-836, 1998.
177. Zhang, H., Wang, P., Bardett, M. G. and Stewart, J. T. HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products. J. Pharm. Biomed. Anal. 16:1241-1249, 1998.
178. Taylor, S. and Preece, S. The use of LC-API/MS with photodiode array detection for the determination of impurities in drug synthesis. Am. Biotechnol. Lab. 16:29-30, 1998.
179. Zhao, Z., Wang, Q., Tsai, E. W., Qin, X.-Z. and Ip, D. Identification of losartan degradates in stressed tablets by LC-MS and LC-MS/MS. J. Pharm. Biomed. Anal. 20:129-136, 1999.
180. Myung, S.-W., Chang, Y.-J., Min, H.-K., Kim, D.-H., Kim, M., Kang, T., Yoo, E.-A., Sohn, Y. T. and Yim, Y.-H. Characterization of amiodarone metabolites and impurities using liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Rapid Commun. Mass Spectrom. 14:2046-2054, 2000.
181. Feng, W., Liu, H., Chen, G., Malchow, R., Bennett, F., Lin, E., Pramanik, B. and Chan, T.-M. Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS. J. Pharm. Biomed. Anal. 15:545-557, 2001.
182. Franolic, J. D., Lehr, G. J., Barry, T. L. and Petzinger, G. Isolation of a 2:1 hydrochlorothiazide-formaldehyde adduct impurity in hydrochlorothiazide drug substance by preparative chromatography and characterization by electrospray ionization LC-MS. J. Pharm. Biomed. Anal. 26:651-663, 2001.
183. Eckers, C., Haskins, N. and Langridge, J. The use of liquid chromatography combined with a quadrupole time-of-flight analyzer for the identification of trace impurities in drug substance. Rapid Comm. Mass Spectrom. 11:1916-1922, 1997.
184. Unger, S. E. Using mass spectrometry to determine ADME properties in drug discovery. Annu. Rep. Med. Chem. 34:307-316, 1999.
185. Debrauwer, L. Use of LC-MS/MS for xenobiotic metabolism studies in animals. Analusis 28:914-920, 2001.